DASHORI 50MG TABLET

Form: Tablets

Pack Size: 60 TABLETS

Marketed by: TORRENT PHARMACEUTICALS LTD (ONCOLOGY DIV)

MRP: ₹2337.90

TORRENT PHARMACEUTICALS LTD (ONCOLOGY DIV): Dashori 50MG Tablet, 60 tablets, salt dasatinib 50mg. NPPA has revised its MRP from Rs 8,767 to Rs 2,337.90 (73% lower) with effect from 09-11-2026; trade rate Rs 1,781.26. Group: BCR-ABL tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Cipla, Dr. Reddy's, Hetero, Natco, Reliance Life Sciences and others. Handling/counselling: avoid antacids within 2 hours; check co-prescriptions for PPIs. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.